Arrowhead Pharmaceuticals
Price & Volume
Stats
See more52W Range | $9.57-$76.76 |
Market Cap | $9.1B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $829.4M |
Revenue Growth (YoY) | -29.6% |
Gross Profit (12 Mos) | $829.4M |
Diluted EPS | -$0.01 |
News
See moreYahoo Finance • 29 days ago
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance • last month
Arrowhead Pharmaceuticals gets FDA Breakthrough Therapy status for plozasiran
Yahoo Finance • 2 months ago
How Do Sarepta (SRPT)’s Enhanced Safety Moves Reflect Its Approach to Long-Term Risk Management?
Yahoo Finance • 2 months ago
Sector Update: Health Care Stocks Softer Late Afternoon
About
CEO | Dr. Christopher R. Anzalone Ph.D. |
Address | 177 East Colorado Boulevard, Pasadena, CA, United States, 91105 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 711 |
